Evidence map›Paper›PMID 37072528›Full record

ArticleEuropean journal of clinical pharmacology2023

Could carbamazepine-acetazolamide interaction lead to a severe hepatocellular liver injury? an interaction that needs to be uncovered.

Khadija Mansour, Raoudha Slim, Malek Sassi, Nesrine Ben-Sayed, Neila Fathallah, Bouraoui Ouni

Abstract readLetter
PubMed Publisher
In one paragraph

Article in European journal of clinical pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Khadija MansourDepartment of Pharmacology, Fattouma Bourguiba University Hospital, Monastir, Tunisia. khadija.mansour2@gmail.com.
Raoudha SlimLaboratoire de Biophysique Métabolique Et Pharmacologie Appliquée (LR 12ES02), Faculté de Médecine de Sousse, Université de Sousse, Sousse, Tunisia.
Malek SassiFaculty of Pharmacy of Monastir, Monastir, Tunisia.
Nesrine Ben-SayedDepartment of Clinical Hematology, Farhat Hached Hospital, Sousse, Tunisia.
Neila FathallahLaboratoire de Biophysique Métabolique Et Pharmacologie Appliquée (LR 12ES02), Faculté de Médecine de Sousse, Université de Sousse, Sousse, Tunisia.
Bouraoui OuniLaboratoire de Biophysique Métabolique Et Pharmacologie Appliquée (LR 12ES02), Faculté de Médecine de Sousse, Université de Sousse, Sousse, Tunisia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsAcetazolamideBenzodiazepinesCarbamazepineHumansAcetazolamideBenzodiazepinesCarbamazepineacetazolamidecarbamazepinedrug-drug interactionliver injuryprotein plasma binding

Identifiers

PMID37072528

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.